| Lastest Insider Transactions Of HALOZYME THERAPEUTICS, INC. ( HALO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-04-16 | Sell | 20,000 | 38.42 | 768,390 | 2024-04-17 19:22:45 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-04-16 | Option Exercise | 20,000 | 8.11 | 162,200 | 2024-04-17 19:22:45 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-03-26 | Option Exercise | 11,618 | 11.20 | 130,160 | 2024-03-26 19:38:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-03-12 | Sell | 20,000 | 41.95 | 839,100 | 2024-03-13 17:22:18 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-03-12 | Option Exercise | 20,000 | 11.37 | 227,338 | 2024-03-13 17:22:18 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-27 | Sell | 20,000 | 39.75 | 794,923 | 2024-02-28 18:49:54 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-27 | Option Exercise | 7,471 | 8.11 | 60,590 | 2024-02-28 18:49:54 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-16 | Option Exercise | 10,376 | 0.00 | 0 | 2024-02-20 18:59:00 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | 2024-02-16 | Option Exercise | 4,796 | 0.00 | 0 | 2024-02-20 18:55:59 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-02-16 | Option Exercise | 10,422 | 0.00 | 0 | 2024-02-20 18:53:11 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-02-16 | Option Exercise | 37,884 | 0.00 | 0 | 2024-02-20 18:49:54 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-15 | Option Exercise | 3,386 | 0.00 | 0 | 2024-02-16 17:47:15 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-02-15 | Option Exercise | 1,254 | 0.00 | 0 | 2024-02-16 17:41:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-02-15 | Option Exercise | 13,092 | 0.00 | 0 | 2024-02-16 17:39:34 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-02-10 | Option Exercise | 8,133 | 0.00 | 0 | 2024-02-13 16:18:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2024-02-10 | Option Exercise | 2,502 | 0.00 | 0 | 2024-02-13 16:15:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2024-02-10 | Option Exercise | 31,281 | 0.00 | 0 | 2024-02-13 16:12:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-01-16 | Sell | 20,000 | 36.00 | 720,000 | 2024-01-18 16:07:33 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2024-01-16 | Option Exercise | 20,000 | 12.07 | 241,400 | 2024-01-18 16:07:33 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | 2024-01-03 | Option Exercise | 7,611 | 0.00 | 0 | 2024-01-05 16:04:24 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-12-12 | Sell | 20,000 | 40.01 | 800,262 | 2023-12-13 19:48:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-12-12 | Option Exercise | 20,000 | 12.81 | 256,247 | 2023-12-13 19:48:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-11-14 | Sell | 20,000 | 39.43 | 788,670 | 2023-11-16 16:18:48 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-11-14 | Option Exercise | 20,000 | 14.06 | 281,273 | 2023-11-16 16:18:48 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-10-17 | Sell | 10,000 | 36.52 | 365,200 | 2023-10-17 19:28:14 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-10-17 | Option Exercise | 10,000 | 19.98 | 199,800 | 2023-10-17 19:28:14 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-09-19 | Sell | 10,000 | 39.10 | 390,980 | 2023-09-19 16:09:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-09-19 | Option Exercise | 10,000 | 19.98 | 199,800 | 2023-09-19 16:09:57 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-08-29 | Sell | 30,000 | 42.69 | 1,280,730 | 2023-08-31 17:35:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-08-29 | Option Exercise | 30,000 | 13.87 | 416,100 | 2023-08-31 17:35:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-08-22 | Sell | 10,000 | 42.41 | 424,070 | 2023-08-23 17:08:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-08-22 | Option Exercise | 10,000 | 19.68 | 196,778 | 2023-08-23 17:08:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-08-15 | Sell | 30,000 | 43.49 | 1,304,820 | 2023-08-17 17:29:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-08-15 | Option Exercise | 30,000 | 13.87 | 416,100 | 2023-08-17 17:29:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | Daly James M | Directior | 2023-08-11 | Sell | 20,000 | 43.73 | 874,520 | 2023-08-15 16:04:28 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-07-25 | Sell | 30,000 | 43.09 | 1,292,750 | 2023-07-27 16:03:22 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-07-25 | Option Exercise | 30,000 | 13.87 | 416,100 | 2023-07-27 16:03:22 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-07-18 | Sell | 10,000 | 40.43 | 404,300 | 2023-07-19 16:10:02 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-07-18 | Option Exercise | 20,000 | 15.30 | 306,098 | 2023-07-19 16:10:02 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-06-21 | Sell | 10,000 | 36.00 | 360,000 | 2023-06-22 18:20:24 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-06-21 | Option Exercise | 10,000 | 18.41 | 184,100 | 2023-06-22 18:20:24 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-04-18 | Sell | 10,000 | 36.00 | 360,000 | 2023-04-19 18:07:35 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-04-18 | Option Exercise | 10,000 | 18.41 | 184,100 | 2023-04-19 18:07:35 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-27 | Sell | 2,984 | 49.55 | 147,854 | 2023-04-19 18:01:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-27 | Option Exercise | 2,984 | 18.41 | 54,935 | 2023-04-19 18:01:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-03-07 | Sell | 30,000 | 43.82 | 1,314,550 | 2023-03-09 17:04:25 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-03-07 | Option Exercise | 30,000 | 14.66 | 439,800 | 2023-03-09 17:04:25 |
| HALO | HALOZYME THERAPEUTICS, INC. | Henderson Jeffrey William | Directior | 2023-02-28 | Sell | 20,000 | 48.11 | 962,200 | 2023-03-01 18:07:56 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-27 | Sell | 10,000 | 49.55 | 495,483 | 2023-02-28 16:59:40 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-16 | Sell | 2,878 | 49.26 | 141,770 | 2023-02-21 19:05:11 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-16 | Option Exercise | 6,112 | 0.00 | 0 | 2023-02-21 19:05:11 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2023-02-16 | Sell | 2,525 | 49.26 | 124,382 | 2023-02-21 19:00:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2023-02-16 | Option Exercise | 5,094 | 0.00 | 0 | 2023-02-21 19:00:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-16 | Sell | 11,061 | 49.26 | 544,865 | 2023-02-21 18:59:22 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-16 | Option Exercise | 21,010 | 0.00 | 0 | 2023-02-21 18:59:22 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-15 | Sell | 10,000 | 48.39 | 483,940 | 2023-02-17 06:29:03 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-15 | Option Exercise | 3,386 | 0.00 | 0 | 2023-02-17 06:29:03 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2023-02-15 | Option Exercise | 1,254 | 0.00 | 0 | 2023-02-17 06:25:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-15 | Option Exercise | 13,092 | 0.00 | 0 | 2023-02-17 06:20:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-02-10 | Option Exercise | 16,016 | 0.00 | 0 | 2023-02-14 17:24:29 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBrosse Nicole | SVP, CHIEF FINANCIAL OFFICER | 2023-02-10 | Option Exercise | 3,892 | 0.00 | 0 | 2023-02-14 17:21:01 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-10 | Option Exercise | 64,075 | 0.00 | 0 | 2023-02-14 17:17:45 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-07 | Sell | 30,000 | 51.01 | 1,530,150 | 2023-02-09 17:44:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-02-07 | Option Exercise | 30,000 | 14.66 | 439,800 | 2023-02-09 17:44:09 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-01-17 | Sell | 30,000 | 51.30 | 1,539,149 | 2023-01-19 17:07:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2023-01-17 | Option Exercise | 30,000 | 14.66 | 439,800 | 2023-01-19 17:07:31 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2023-01-17 | Sell | 10,000 | 50.46 | 504,590 | 2023-01-18 19:07:51 |
| HALO | HALOZYME THERAPEUTICS, INC. | Snyder Mark Howard | SVP, GENERAL COUNSEL | 2023-01-03 | Option Exercise | 7,611 | 0.00 | 0 | 2023-01-04 18:00:58 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2022-12-13 | Sell | 30,000 | 58.11 | 1,743,302 | 2022-12-15 19:12:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | PRESIDENT AND CEO | 2022-12-13 | Option Exercise | 30,000 | 14.66 | 439,800 | 2022-12-15 19:12:37 |
| HALO | HALOZYME THERAPEUTICS, INC. | LaBarre Michael J. | SVP, CHIEF TECHNICAL OFFICER | 2022-12-13 | Sell | 10,000 | 58.67 | 586,675 | 2022-12-13 18:09:50 |
